Daniel Arber

NPI: 1174614267
Total Payments
$47,332
2024 Payments
$123.12
Companies
10
Transactions
30
Medicare Patients
1,179
Medicare Billing
$47,458

Payment Breakdown by Category

Consulting$41,903 (88.5%)
Other$2,464 (5.2%)
Research$1,500 (3.2%)
Travel$793.31 (1.7%)
Food & Beverage$613.14 (1.3%)
Education$58.50 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $41,903 16 88.5%
Honoraria $2,464 1 5.2%
Unspecified $1,500 1 3.2%
Travel and Lodging $793.31 3 1.7%
Food and Beverage $613.14 8 1.3%
Education $58.50 1 0.1%

Payments by Type

General
$45,832
29 transactions
Research
$1,500
1 transactions

Top Paying Companies

Company Total Records Latest Year
JAZZ PHARMACEUTICALS INC. $15,297 15 $0 (2024)
Novartis Pharmaceuticals Corporation $8,640 3 $0 (2021)
Astellas Pharma Global Development $8,250 3 $0 (2021)
Amgen Inc. $5,688 2 $0 (2021)
Blueprint Medicines Corporation $2,523 2 $0 (2022)
Eli Lilly and Company $2,400 1 $0 (2021)
AbbVie Inc. $1,575 1 $0 (2021)
Celgene Corporation $1,500 1 $0 (2017)
Roche Diagnostics International Ltd $1,400 1 $0 (2020)
E.R. Squibb & Sons, L.L.C. $59.26 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $123.12 1 JAZZ PHARMACEUTICALS INC. ($123.12)
2023 $1,200 1 JAZZ PHARMACEUTICALS INC. ($1,200)
2022 $12,076 13 JAZZ PHARMACEUTICALS INC. ($9,494)
2021 $17,713 8 Astellas Pharma Global Development ($8,250)
2020 $5,800 2 Amgen Inc. ($4,400)
2019 $129.90 1 JAZZ PHARMACEUTICALS INC. ($129.90)
2018 $5,190 2 Jazz Pharmaceuticals Inc. ($3,750)
2017 $5,100 2 Novartis Pharmaceuticals Corporation ($3,600)

All Payment Transactions

30 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/07/2024 JAZZ PHARMACEUTICALS INC. RYLAZE (Drug), VYXEOS, Defitelio Food and Beverage In-kind items and services $123.12 General
Category: HEMATOLOGY/ONCOLOGY
02/17/2023 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Consulting Fee Cash or cash equivalent $1,200.00 General
Category: HEMATOLOGY/ONCOLOGY
12/21/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Consulting Fee Cash or cash equivalent $7,800.00 General
Category: HEMATOLOGY/ONCOLOGY
12/21/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Travel and Lodging Cash or cash equivalent $126.57 General
Category: HEMATOLOGY/ONCOLOGY
11/30/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Food and Beverage In-kind items and services $75.00 General
Category: HEMATOLOGY/ONCOLOGY
11/30/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Food and Beverage In-kind items and services $50.00 General
Category: HEMATOLOGY/ONCOLOGY
11/30/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Food and Beverage In-kind items and services $25.00 General
Category: HEMATOLOGY/ONCOLOGY
11/30/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Food and Beverage In-kind items and services $25.00 General
Category: HEMATOLOGY/ONCOLOGY
11/29/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Travel and Lodging Cash or cash equivalent $421.21 General
Category: HEMATOLOGY/ONCOLOGY
11/29/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Travel and Lodging Cash or cash equivalent $245.53 General
Category: HEMATOLOGY/ONCOLOGY
11/29/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Food and Beverage In-kind items and services $125.86 General
Category: HEMATOLOGY/ONCOLOGY
10/20/2022 Blueprint Medicines Corporation Honoraria Cash or cash equivalent $2,464.00 General
09/26/2022 Blueprint Medicines Corporation Education In-kind items and services $58.50 General
01/17/2022 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $59.26 General
01/13/2022 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Consulting Fee Cash or cash equivalent $600.00 General
Category: HEMATOLOGY/ONCOLOGY
12/17/2021 JAZZ PHARMACEUTICALS INC. VYXEOS (Drug) Consulting Fee Cash or cash equivalent $600.00 General
Category: HEMATOLOGY/ONCOLOGY
08/11/2021 Amgen Inc. Blincyto (Biological) Consulting Fee Cash or cash equivalent $1,288.00 General
Category: Oncology
06/25/2021 Eli Lilly and Company Consulting Fee Cash or cash equivalent $2,400.00 General
04/28/2021 Astellas Pharma Global Development XOSPATA (Drug) Consulting Fee Cash or cash equivalent $2,750.00 General
Category: ONCOLOGY
03/31/2021 Astellas Pharma Global Development XOSPATA (Drug) Consulting Fee Cash or cash equivalent $2,750.00 General
Category: ONCOLOGY
03/19/2021 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $3,600.00 General
02/18/2021 AbbVie Inc. Consulting Fee Cash or cash equivalent $1,575.00 General
02/12/2021 Astellas Pharma Global Development XOSPATA (Drug) Consulting Fee Cash or cash equivalent $2,750.00 General
Category: ONCOLOGY
09/24/2020 Roche Diagnostics International Ltd RDI Research (Device) Consulting Fee Cash or cash equivalent $1,400.00 General
Category: Point of Care
09/04/2020 Amgen Inc. Blincyto (Biological) Consulting Fee Cash or cash equivalent $4,400.00 General
Category: Oncology

Research Studies & Clinical Trials

Study Name Company Amount Records
CC-5013-AML-001 Celgene Corporation $1,500 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 235 369 $96,469 $9,625
2022 8 280 404 $99,166 $10,567
2021 9 356 525 $127,037 $13,954
2020 8 308 481 $114,109 $13,312
Total Patients
1,179
Total Services
1,779
Medicare Billing
$47,458
Procedure Codes
32

All Medicare Procedures & Services

32 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 46 95 $26,604 $2,819 10.6%
85097 Bone marrow, smear interpretation Facility 2023 45 53 $19,366 $2,118 10.9%
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers Facility 2023 24 27 $22,050 $1,889 8.6%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2023 46 108 $9,561 $1,058 11.1%
88188 Flow cytometry technique for dna or cell analysis, 9 to 15 markers Facility 2023 14 14 $9,372 $725.48 7.7%
88311 Preparation of tissue for examination by removing any calcium present Facility 2023 45 56 $5,292 $564.94 10.7%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2023 15 16 $4,224 $450.72 10.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2022 53 97 $26,222 $2,973 11.3%
85097 Bone marrow, smear interpretation Facility 2022 52 54 $19,048 $2,197 11.5%
88188 Flow cytometry technique for dna or cell analysis, 9 to 15 markers Facility 2022 22 24 $15,492 $1,289 8.3%
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers Facility 2022 18 18 $14,136 $1,288 9.1%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2022 53 110 $9,396 $1,122 11.9%
88311 Preparation of tissue for examination by removing any calcium present Facility 2022 53 55 $4,999 $576.77 11.5%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2022 11 27 $5,043 $576.06 11.4%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2022 18 19 $4,830 $545.48 11.3%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2021 67 119 $30,895 $3,642 11.8%
85097 Bone marrow, smear interpretation Facility 2021 60 66 $22,394 $2,660 11.9%
88189 Flow cytometry technique for dna or cell analysis, 16 or more markers Facility 2021 25 29 $21,995 $2,108 9.6%
88313 Special stained specimen slides to examine tissue including interpretation and report Facility 2021 63 142 $11,715 $1,399 11.9%
88188 Flow cytometry technique for dna or cell analysis, 9 to 15 markers Facility 2021 24 24 $14,928 $1,244 8.3%
88342 Special stained specimen slides to examine tissue, initial procedure Facility 2021 26 29 $7,100 $854.05 12.0%
88311 Preparation of tissue for examination by removing any calcium present Facility 2021 63 69 $6,036 $707.15 11.7%
88341 Special stained specimen slides to examine tissue, each additional procedure Facility 2021 11 28 $5,054 $671.16 13.3%
88360 Microscopic genetic analysis of tumor, manual Facility 2021 17 19 $6,920 $669.36 9.7%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2020 61 119 $29,835 $3,802 12.7%

About Daniel Arber

Daniel Arber is a Anatomic Pathology & Clinical Pathology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174614267.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Arber has received a total of $47,332 in payments from pharmaceutical and medical device companies, with $123.12 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($41,903).

As a Medicare-enrolled provider, Arber has provided services to 1,179 Medicare beneficiaries, totaling 1,779 services with total Medicare billing of $47,458. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.

Practice Information

Products in Payments

  • VYXEOS (Drug) $15,174
  • XOSPATA (Drug) $8,250
  • Blincyto (Biological) $5,688
  • RYDAPT (Drug) $5,040
  • Revlimid (Drug) $1,500
  • RDI Research (Device) $1,400
  • RYLAZE (Drug) $123.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Chicago